help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Published ahead of print on August 28, 2002, doi:10.1164/rccm.200204-345OC

Am. J. Respir. Crit. Care Med., Volume 166, Number 10, November 2002, 1396-1402

A more recent version of this article appeared on November 15, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200204-345OCv1
166/10/1396    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aldashev, A. A
Right arrow Articles by Morrell, N. W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aldashev, A. A
Right arrow Articles by Morrell, N. W

Submitted on April 18, 2002
Accepted on August 23, 2002

Characterization of high altitude pulmonary hypertension in the Kyrgyz: Association with ACE genotype

Almaz A Aldashev1, Akpay S Sarybaev1, Akyl S Sydykov1, Bolot B Kalmyrzaev1, Elena V Kim1, Lira B Mamanova1, Rashid Maripov1, Baktybek K Kojonazarov1, Mirsaid M Mirrakhimov1, Martin R Wilkins2, and Nicholas W Morrell3*

1 Laboratory of Molecular Biology, National Center for Cardiology and Internal Medicine, Bishkek, Kyrgyzstan, 2 Section on Clinical Pharmacology, Imperial College School of Medicine, London, United Kingdom, 3 Department of Medicine, University of Cambridge, Cambridge, United Kingdom

* To whom correspondence should be addressed. E-mail: nwm23{at}cam.ac.uk.

Previous studies have suggested a genetic component to the susceptibility to hypoxia-induced pulmonary hypertension. Thus we estimated the prevalence of high altitude pulmonary hypertension (HAPH) in a Kyrgyz population and whether the insertion/deletion (I/D) polymorphism of the ACE gene associates with HAPH. An electrocardiographic survey of 741 highlanders demonstrated ECG signs of cor pulmonale in 14% of subjects. Pulmonary artery hemodynamics measured in an independent group of 136 male highlanders with symptoms at altitude, revealed established pulmonary hypertension (MPAP>=25mmHg) in 20%. However, 26% of the normal subjects demonstrated an exaggerated response (>=2-fold increase in MPAP) to inhalation of 11% oxygen, and were classified as hyper-responsive. 10 year follow up of this group revealed increases in the MPAP, but not in normals. Comparison of ACE I/D genotypes in the catheterized group revealed a 3-fold higher frequency of the I/I genotype in highlanders with HAPH, compared with normal highlanders ({chi} 11.59, p=0.003). In addition, MPAP was higher in highlanders with the I/I (26.9±4.0mmHg) compared with the I/D (20.6±1.2mmHg, or the D/D genotype (18.3±0.9mmHg) (P<0.05). We conclude that HAPH is associated with ACE I/D genotype amongst Kyrgyz highlanders and the development of HAPH in this population may be predicted by hyper-responsiveness to acute hypoxia.
Key words: pulmonary hypertension, hypoxia, angiotensin converting enzyme,altitude




This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
V. G. DeMarco, J. Habibi, A. T. Whaley-Connell, R. I. Schneider, R. L. Heller, J. P. Bosanquet, M. R. Hayden, K. Delcour, S. A. Cooper, B. T. Andresen, et al.
Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2659 - H2668.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. M. Luks and E. R. Swenson
Travel to high altitude with pre-existing lung disease
Eur. Respir. J., April 1, 2007; 29(4): 770 - 792.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
D. Penaloza and J. Arias-Stella
The Heart and Pulmonary Circulation at High Altitudes: Healthy Highlanders and Chronic Mountain Sickness
Circulation, March 6, 2007; 115(9): 1132 - 1146.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J. Bousquet, R. Dahl, and N. Khaltaev
Global Alliance against Chronic Respiratory Diseases
Eur. Respir. J., February 1, 2007; 29(2): 233 - 239.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
B. K. Kojonazarov, B. Z. Imanov, T. A. Amatov, M. M. Mirrakhimov, R. Naeije, M. R. Wilkins, and A. A. Aldashev
Noninvasive and invasive evaluation of pulmonary arterial pressure in highlanders
Eur. Respir. J., February 1, 2007; 29(2): 352 - 356.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A A Aldashev, B K Kojonazarov, T A Amatov, T M Sooronbaev, M M Mirrakhimov, N W Morrell, J Wharton, and M R Wilkins
Phosphodiesterase type 5 and high altitude pulmonary hypertension
Thorax, August 1, 2005; 60(8): 683 - 687.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. J. Barnes and R. A. Stockley
COPD: current therapeutic interventions and future approaches
Eur. Respir. J., June 1, 2005; 25(6): 1084 - 1106.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. Humbert, O. Sitbon, and G. Simonneau
Treatment of Pulmonary Arterial Hypertension
N. Engl. J. Med., September 30, 2004; 351(14): 1425 - 1436.
[Full Text] [PDF]

Home page
 ChestHome page
J. Hotta, M. Hanaoka, Y. Droma, Y. Katsuyama, M. Ota, and T. Kobayashi
Polymorphisms of Renin-Angiotensin System Genes With High-Altitude Pulmonary Edema in Japanese Subjects
Chest, September 1, 2004; 126(3): 825 - 830.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
S. Y. Lam, M.-L. Fung, and P. S. Leung
Regulation of the angiotensin-converting enzyme activity by a time-course hypoxia in the carotid body
J Appl Physiol, February 1, 2004; 96(2): 809 - 813.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
T Duke
Hypoxaemia in developing countries
Arch. Dis. Child., April 1, 2003; 88(4): 365 - 365.
[Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 356 - 370.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society